Poland· PL-100456190
Rivaroxaban Farmak
A medicinal product containing rivaroxabanum, registered in Poland by Farmak International Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Rivaroxabanum
- Manufacturer
- Farmak International Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991516406
- gtin05909991516413
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rivaroxabanum in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXALTRA+pharma arzneimittel gmbh, Graz
- SpainBLOMENSY 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEgis Pharmaceuticals Plc.
- SwedenBevimlar 15 mg + 20 mg Filmdragerad tablettSTADA Arzneimittel AG
- SwitzerlandRivarax 15 mg, FilmtablettenDrossapharm AG
- NetherlandsBlomensy 15 mg filmomhulde tablettenEgis Pharmaceuticals Plc
- IrelandRivaroxaban 15 mg film-coated tabletsRenata Pharmaceuticals (Ireland) Limited
- BelgiumBlomensy 15 mgProterapia Hungary
- FinlandDovequaBausch Health Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Rivahib, Rivaroksaban Grindeks
- Belgium · Rivaroxaban, Rivaroxaban Eg
- Bulgaria · Xaboplax Sandoz Pharmaceuticals D.D, Виатрикс
- Cyprus · Enkia, Naxat
- Czechia · Axaltra, Bevimlar
- Germany · Elmardya, Rivadia
- Denmark · Blomensy, Dovequa
- Estonia · Enkia, Kardatuxan
- Spain · Blomensy, Elmardya
- Finland · Blomensy, Dovequa
- France · Elmardya, Rivaroxaban Almus
- United Kingdom (Northern Ireland) · Rivaroxaban, Rivaroxaban Abdi
- Greece · Blomensy, Cinstel
- Croatia · Aban, Bevimlar
- Hungary · Dovequa, Evoxyr
- Ireland · Rivaroxaban Ascend, Rivaroxaban Azure
- Iceland · Agublon, Barsovi
- Italy · Ellebax, Indifaxa
- Liechtenstein · Rivaroxaban Accord, Rivaroxaban Viatris
- Lithuania · Enkia, Kardatuxan
- Luxembourg · Rivaroxaban Eg, Rivaroxaban Eg (Eurogenerics) Nv
- Latvia · Kardatuxan, Mibrex
- Malta · Enkia, Naxat
- Netherlands · Blomensy, Rivaroksaban Grindeks
- Norway · Dovequa, Rivaroxaban Accord
- Portugal · Closderive, Enkia
- Romania · Closderive, Enkia
- Sweden · Bevimlar, Blomensy
- Slovenia · Dovequa, Ribas
- Slovakia · Assubex, Bevimlar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be09eaad-22c1-4b15-8854-bf63bede5f13 GET /v1/drugs/be09eaad-22c1-4b15-8854-bf63bede5f13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "15 mg",
"packaging": "05909991516406 ¦ Rp ¦ 150353\n14 tabl.\n05909991516413 ¦ Rp ¦ 150354\n28 tabl.",
"substance": "Rivaroxabanum 15 mg",
"common_name": "Rivaroxabanum",
"pl_product_id": "100456190",
"pozwolenie_nr": "27887",
"auth_procedure": "DCP",
"authorisation_validity": "2028-06-20"
}See everything about rivaroxabanum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.